[醋酸格拉替雷（考帕松）在多发性硬化症患者治疗中的应用。莫斯科多发性硬化症中心的经验]

[Use of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience of the Moscow multiple sclerosis center].

作者信息

Demina T L, Davydovskaia M V, Lashch N Iu, Popova N F, Khachanova N V, Zhuchenko T D

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2003(Spec No 2):91-7.

Abstract

146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre. The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment. EDSS score did not increase both in group with and without relapses. The condition of 2/3 patients was stable. To achieve the best effect of treatment the program of patient support was successfully used in the Moscow MS Centre.

摘要

146例多发性硬化症患者在莫斯科多发性硬化症中心接受了考帕松治疗。在考帕松治疗期间，复发-加重率下降了72%，复发率降低了25.6%。无论有无复发，扩展残疾状态量表（EDSS）评分均未增加。三分之二患者的病情稳定。为了达到最佳治疗效果，莫斯科多发性硬化症中心成功采用了患者支持方案。